H.E.L Group extends sales and support with appointment of specialist distributors

FHS
May 31, 2024
12:35 pm

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the extension of its global sales network with the appointment of two distributors: Paralab and ProAnalytics.

Three Years After COVID Hospitalization, Cognitive Problems Persist and Worsen

Some early COVID patients showed cognitive deficits up to 3 years after hospitalization. Symptoms at 2 to 3 years were not predicted by severity of

August 7, 2024

NK cells’ role in cancer therapy resistance unveiled

Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune

May 4, 2024

UCB adds three more FDA approvals to label for potential blockbuster Bimzelx

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.